Buy S-23 Capsules
€ 39,95
S-23 capsules contain a formulated presentation of a substituted propanamide androgen-receptor research compound offered by Raw Lab Chems with seller-specified ≥99% purity. The material is intended exclusively for controlled in-vitro, chemical, and analytical research.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
S-23 Capsules
Product Overview
S-23 capsules provide a formulated presentation of S-23, a synthetic substituted propanamide commonly classified in scientific research as a selective androgen receptor modulator (SARM). The compound has been investigated experimentally in connection with androgen-receptor signaling and tissue-selective receptor activity.
Raw Lab Chems presents this material exclusively for controlled in-vitro, chemical, and analytical research. The supplied specification states ≥99% purity for the research compound. This value is treated as a seller-provided specification rather than independent analytical verification.
The supplied source discusses S-23 in relation to androgen-receptor modulation, gonadotropin signaling, protein-related pathways, and bone-related cellular research. These subjects describe experimental areas of investigation rather than established medical, hormonal, contraceptive, bodybuilding, or athletic applications.
Researchers should distinguish observations from preclinical or cellular models from established effects in humans or animals. The formulation is intended to support laboratory investigation and analytical characterization rather than personal use.
Chemical Identity & Classification
The supplied systematic chemical name for S-23 is (S)-3-(4-chloro-3-fluorophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide.
The supplied molecular formula is C18H13ClF4N2O3. The material is classified in the provided information as a substituted propanamide / SARM.
Its systematic name identifies several structurally relevant features, including chloro, fluoro, trifluoromethyl, cyano, phenoxy, hydroxy, and propanamide functionality. The supplied “(S)” designation also specifies stereochemistry and should be retained in identity-sensitive laboratory documentation.
No molecular weight or CAS number was provided in this capsule-specific source. Those values are therefore not introduced as supplied product specifications.
Researchers can consult PubChem when reviewing public chemical-reference information, while ensuring that any selected record corresponds to the precise compound and stereochemical form under investigation.
Chemical & Physical Characteristics
The supplied formulation is described as encapsulated powder for laboratory measurement. No verified capsule color, shell composition, dimensions, fill appearance, excipient composition, or other formulation-specific physical characteristics were provided.
The molecular formula C18H13ClF4N2O3 describes the underlying S-23 compound rather than the complete capsule formulation. Any excipients or capsule-shell materials would represent additional formulation components and should not be incorporated into molecular calculations for S-23 itself.
No quantitative solubility, melting point, density, particle-size distribution, or other physical-property measurements were supplied in the capsule source.
The supplied storage information specifies a cool, dry environment between 15°C and 25°C with protection from moisture and direct UV light. No product-specific stability study or validated shelf-life dataset was supplied to establish long-term stability under these conditions.
Purity & Analytical Verification
The supplied specification for S-23 capsules states ≥99% purity for the research compound.
The source additionally states that HPLC is used to assess chemical purity and formulation concentration. Mass spectrometry and proton NMR are described as methods used to verify structural features of S-23. No batch-specific chromatogram, mass spectrum, NMR spectrum, or independent laboratory report accompanied the supplied information.
The ≥99% value is therefore presented as seller-specified rather than independently verified analytical data.
HPLC, LC-MS, GC-MS, NMR, and related techniques can be relevant to laboratory characterization of S-23 when appropriately validated for the intended analytical objective. Such methods can support investigation of identity, purity, impurities, structural characteristics, and differentiation from related research compounds.
For formulated materials, chemical purity and formulation uniformity are separate analytical characteristics. A stated purity value for the underlying research compound does not independently establish the composition or uniformity of every formulated unit.
Quality Control & Batch Integrity
The supplied information states that batches undergo HPLC analysis and that mass spectrometry and proton NMR are used for structural characterization. It also describes manufacturing controls intended to support consistency across research material.
No underlying chromatograms, spectra, manufacturing records, validation data, or other batch-specific analytical documentation was provided. These statements are therefore treated as supplied quality information rather than independently established facts.
Reliable research records can include the product identity, supplier, lot or batch identifier, receipt date, storage history, formulation information, and analytical observations. Maintaining these records can help connect experimental findings with the exact material investigated.
When formulation uniformity is important to an analytical study, it should be established through appropriate documentation or validated laboratory analysis rather than inferred solely from the nominal formulation.
Safety, Handling & Laboratory Precautions
S-23 should be handled only by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access restrictions, and waste-management procedures should be determined through institutional risk assessment and applicable safety documentation.
The compound’s experimental association with androgen-receptor signaling should be considered when establishing appropriate laboratory controls. Experimental molecular activity does not establish safety for human or veterinary exposure.
Researchers should consult an applicable Safety Data Sheet for the exact material and formulation when developing procedures concerning accidental exposure, spills, contamination, environmental release, waste collection, and disposal.
Research materials should be secured against unauthorized access and kept away from children, pets, food, beverages, and non-research environments.
Packaging, Labeling & Storage
The supplied information describes high-barrier, moisture-resistant, and UV-protective packaging. No packaging specification, validation study, or supporting technical documentation was supplied to independently confirm those characteristics.
Storage information specifies dry conditions between 15°C and 25°C with protection from moisture and direct UV light. These are retained as supplied storage conditions rather than presented as independently validated Raw Lab Chems stability specifications.
Researchers should follow documentation applicable to the specific material, relevant SDS guidance, and institutional chemical-storage requirements.
Because the product is formulated in capsules, laboratory labeling and records should distinguish the complete formulation from isolated S-23 reference material. Storage history should also be documented where environmental conditions could influence analytical observations or formulation integrity.
Intended Research Use & Market Positioning
S-23 is relevant to laboratory investigation of androgen-receptor signaling, tissue-selective receptor modulation, ligand-receptor interactions, comparative SARM chemistry, and analytical method development. The supplied material also identifies investigation of gonadotropin-related signaling and comparison of halogenated SARM analogues as research contexts.
References to protein synthesis, bone-related models, endocrine signaling, or receptor selectivity describe areas of experimental investigation. They do not establish medical, therapeutic, hormonal, contraceptive, muscle-building, or performance applications.
Researchers comparing different formats can separately examine Raw Lab Chems S-23 Powder and the YK-11 Powder (Myostine) research material. These products represent different formulations or compounds and should not be treated as chemically or analytically interchangeable.
The Raw Lab Chems S-23 Capsules research listing provides the catalog reference for the formulation described here.
No medical, therapeutic, diagnostic, veterinary, hormonal, contraceptive, bodybuilding, muscle-building, athletic-performance, or consumptive application is represented by this description.
Ordering, Availability & Fulfillment
Institutional procurement of S-23 capsules should begin with confirmation of the required formulation, chemical identity, analytical documentation, institutional authorization, and jurisdiction-specific requirements relevant to the proposed research.
The supplied source refers to standardized laboratory counts but does not provide verified current inventory or package-count information. Availability should therefore not be inferred from this description.
The source additionally describes moisture-resistant packaging and discreet worldwide shipping. These statements are not presented as verified Raw Lab Chems fulfillment guarantees because supporting logistics documentation was not supplied.
No claims are made concerning current stock, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking, payment methods, customs processing, or geographic availability.
Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of the material are appropriately authorized.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
S-23 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended activity, institutional policy, and applicable medicines, sporting, chemical-control, or research frameworks.
Researchers and institutions are responsible for identifying and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.
A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.
You must be logged in to post a review.

Reviews
There are no reviews yet.